Product image of Glukose B. Braun (Glucose, Anhydrous) supplied by GNH India

Glukose B. Braun

Active Ingredient:
Glucose, Anhydrous
Origin:
EU

Glukose B. Braun (Glucose, Anhydrous)

Glukose B. Braun is a parenteral preparation containing glucose (anhydrous) as the sole active ingredient. It is supplied in a sterile solution for intramuscular, intravenous, or subcutaneous administration. The product is manufactured in the European Union and is classified as an excipient rather than a therapeutic drug. Glukose B. Braun provides a readily available source of carbohydrate for clinical use. It is used in hospital and outpatient settings.

Manufacturer / TM Owner

B.Braun Melsungen Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glukose B. Braun is employed in clinical practice where a rapid source of carbohydrate is required. It can be administered intravenously, subcutaneously, or intramuscularly depending on the clinical situation.

  • Treatment of hypoglycemia when oral glucose is not feasible.
  • Provision of calories during parenteral nutrition.
  • Diluent or carrier for other intravenous medications.
  • Fluid replacement in patients needing both volume and glucose.
  • Support during diagnostic procedures that require glucose infusion.

Side Effects

Side effects of Glukose B. Braun are generally related to its osmolarity and glucose content. Most reactions are mild, but serious events can occur in susceptible individuals.

Common

  • Local irritation at the injection site.
  • Mild hyperglycemia.
  • Nausea or vomiting.
  • Headache.
  • Transient electrolyte shifts.

Serious

  • Severe hyperglycemia leading to ketoacidosis.
  • Fluid overload or pulmonary edema.
  • Allergic reaction or anaphylaxis.
  • Severe electrolyte imbalance (e.g., hyponatremia).

Precautions & Warnings

When using Glukose B. Braun, clinicians should consider patient-specific factors and monitor for potential complications.

  • Assess blood glucose levels before and after administration.
  • Use caution in patients with diabetes, renal impairment, or heart failure.
  • Monitor fluid balance to avoid overload.
  • Adjust dosage in pediatric or geriatric populations.
  • Ensure proper aseptic technique to prevent infection.
  • Discontinue if signs of allergic reaction develop.

Avoid Interactions

Glukose B. Braun may interact with other medications that affect glucose metabolism or fluid balance. Awareness of these interactions helps prevent adverse outcomes.

Avoid

  • Concurrent high-dose insulin without glucose monitoring.
  • Medications that cause severe hypoglycemia (e.g., sulfonylureas) without appropriate glucose supplementation.

Use with caution

  • Beta‑blockers, which may mask hypoglycemia symptoms.
  • Diuretics that can alter electrolyte status.
  • Corticosteroids, which may increase blood glucose levels.
  • Cardiovascular drugs that affect fluid status (e.g., ACE inhibitors).

Frequently Asked Questions

The primary active ingredient is glucose (anhydrous), supplied as a sterile solution for parenteral use.

Glukose B. Braun can be administered intravenously, intramuscularly, or subcutaneously.

Yes, it is commonly used to rapidly raise blood glucose levels in patients with hypoglycemia when oral glucose is not feasible.

It may be used in pediatric patients, but dosing should be adjusted based on age, weight, and clinical condition, and close monitoring is required.

Blood glucose levels, fluid balance, and electrolytes should be monitored before, during, and after infusion.

Common side effects include local irritation at the injection site, mild hyperglycemia, nausea, headache, and transient electrolyte shifts.

Discontinue if the patient develops signs of an allergic reaction, severe hyperglycemia, fluid overload, or any serious adverse event.

Concurrent high-dose insulin can cause severe hypoglycemia; glucose levels should be closely monitored and insulin doses adjusted as needed.

There are no absolute contraindications, but caution is advised in patients with uncontrolled diabetes, severe renal or cardiac disease, or known hypersensitivity to glucose solutions.

Store the product at controlled room temperature, protected from light, and keep the vial sealed until use.

Yes, it can serve as a carrier or diluent for certain intravenous drugs, provided compatibility is confirmed.

Glukose B. Braun is manufactured in the European Union and complies with EU pharmaceutical standards for sterile parenteral solutions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glucose, Anhydrous

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT